Familial mediterranean fever overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Familial | [[Familial mediterranean fever|Familial Mediterranean fever]] | ||
==Historical Perspective== | ==Historical Perspective== | ||
[[Familial mediterranean fever|Familial Mediterranean fever]] was first described in a Jewish schoolgirl by Janeway and Mosenthal in 1908. In 1955, Dr. Heller called this disorder [[Familial mediterranean fever|familial Mediterranean fever]], which refers to its high [[prevalence]] in this region and the key presenting feature of [[Familial mediterranean fever|periodic fever]]. The [[disease]] was life-threatening before the introduction of [[colchicine]] in 1972. | |||
==Classification== | |||
There is no established system for the [[classification]] of [[familial Mediterranean fever]]. However, [[familial Mediterranean fever]] may be classified according to [[Phenotype|phenotypic]] manifestation into three subtypes/groups: type 1, type 2, and type 3. | |||
==Pathophysiology== | |||
The exact [[pathogenesis]] of [[familial mediterranean fever]] is not fully understood. However, nearly all the cases are due to a [[mutation]] in the [[MEFV]] [[gene]], which codes for a [[protein]] called pyrin. Normally, pyrin regulates the production of [[Interleukin-1|interleukin-1β]] (IL-1β), an important [[pro-inflammatory]] [[cytokine]]. When [[mutation]] occurs, [[mutated]] protein is unable to suppress expression of IL-1β, therefore an inflammatory response would develop results in clinical manifestation of [[FMF]]. The [[disease]] inherits in an [[autosomal recessive]] mode. However, there is an increasing number of data reporting the [[autosomal dominant]] [[inheritance]]. | |||
==Causes== | |||
[[Familial Mediterranean fever]] is most often [[Causes|caused]] by a [[mutation]] in the [[MEFV]] [[gene]]. This [[gene]] creates [[proteins]] involved in [[inflammation]]. There are also reports of [[FMF]] cases in the absence of causative [[gene]] in the [[genetic screening]]. | |||
==Epidemiology and demographics== | |||
The [[incidence]] of [[familial mediterranean fever]] is estimated 100 per 100,000 individuals worldwide. The [[prevalence]] of [[familial mediterranean fever]] differs widely according to the geographic area. In the non- Ashkenazi Jews, it ranges from 100 to 400 per 100,000 individuals. [[Patients]] of all age groups may develop the [[Familial mediterranean fever|familial Mediterranean fever]] ([[FMF]]). However, it usually manifests during Childhood. This [[disorder]] usually affects individuals of the Turkish, Armenian, Jewish and Arabic communities. However, it is also common among western societies such as Italy, Greece, Crete, France, and Germany. | |||
==Risk factors== | |||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
===Other Diagnostic Studies=== | ===Other Diagnostic Studies=== | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
==References== | ==References== | ||
Revision as of 02:36, 5 June 2019
|
Familial Mediterranean Fever Microchapters |
|
Differentiating Familial Mediterranean Fever from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Familial mediterranean fever overview On the Web |
|
American Roentgen Ray Society Images of Familial mediterranean fever overview |
|
Directions to Hospitals Treating Familial mediterranean fever |
|
Risk calculators and risk factors for Familial mediterranean fever overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Familial Mediterranean fever was first described in a Jewish schoolgirl by Janeway and Mosenthal in 1908. In 1955, Dr. Heller called this disorder familial Mediterranean fever, which refers to its high prevalence in this region and the key presenting feature of periodic fever. The disease was life-threatening before the introduction of colchicine in 1972.
Classification
There is no established system for the classification of familial Mediterranean fever. However, familial Mediterranean fever may be classified according to phenotypic manifestation into three subtypes/groups: type 1, type 2, and type 3.
Pathophysiology
The exact pathogenesis of familial mediterranean fever is not fully understood. However, nearly all the cases are due to a mutation in the MEFV gene, which codes for a protein called pyrin. Normally, pyrin regulates the production of interleukin-1β (IL-1β), an important pro-inflammatory cytokine. When mutation occurs, mutated protein is unable to suppress expression of IL-1β, therefore an inflammatory response would develop results in clinical manifestation of FMF. The disease inherits in an autosomal recessive mode. However, there is an increasing number of data reporting the autosomal dominant inheritance.
Causes
Familial Mediterranean fever is most often caused by a mutation in the MEFV gene. This gene creates proteins involved in inflammation. There are also reports of FMF cases in the absence of causative gene in the genetic screening.
Epidemiology and demographics
The incidence of familial mediterranean fever is estimated 100 per 100,000 individuals worldwide. The prevalence of familial mediterranean fever differs widely according to the geographic area. In the non- Ashkenazi Jews, it ranges from 100 to 400 per 100,000 individuals. Patients of all age groups may develop the familial Mediterranean fever (FMF). However, it usually manifests during Childhood. This disorder usually affects individuals of the Turkish, Armenian, Jewish and Arabic communities. However, it is also common among western societies such as Italy, Greece, Crete, France, and Germany.